Uncategorized
VIDEO: Aflibercept ‘greatly reduced’ rates of vision-threatening complications in diabetic retinopathy
CHICAGO — At the American Society of Retina Specialists meeting, W. Lloyd Clark, MD, discusses his presentation on the PANORAMA study for the treatment of diabetic retinopathy with Eylea (aflibercept, Regeneron) and results at 1 year.